DePuy Spine will market a genetic test for scoliosis made by Salt Lake City-based Axial Biotech Inc.
About 100,000 U.S. children are diagnosed with scoliosis, or abnormal lateral curvature of the spine, every year, according to a press release.
Axial’s ScoliScore AIS Prognostic is a saliva-based genetic test designed to predict the risk of progression of the condition in Caucasian children between 9 and 13 years old diagnosed with mild adolescent idiopathic scoliosis.